DARE (Dare Bioscience, Inc.) Earnings per share growth rate in current year

Official company branding of Dare Bioscience, Inc. (DARE)

Dare Bioscience, Inc. (DARE) optimizes drug production through external CDMO partners to minimize operational downtime. The YoY EPS trend illustrates the annual growth rate of earnings per share, where the 38.50 metric determines this level. Development efficiency is increasing through laboratory robotics, while diversified logistics routes ensure the uninterrupted supply of components for clinical trials.

DARE - Daré Bioscience, Inc. Earnings growth in current year over the range 07/04/2022 - 11/12/2026

Analytical breakdowns and data insights for company Dare Bioscience, Inc. (DARE)

- price and consensus price forecast:
Stock Quotes Dare Bioscience|DARE - Analyst Consensus Forecast
- business market valuation indicators:
Market Value Daré Bioscience, Inc.|DARE - Total Company Value
- balance sheet equity data:
Equity per Share Daré Bioscience|DARE - Book Capitalization|Capitalization to Book Value Ratio darebioscience.com|DARE - Company Total Assets
- debt and liquidity details:
Total Debt to Capital Dare Bioscience, Inc.|DARE - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital darebioscience.com|DARE - Company Aggregate Debts|Debts to Book Value Daré Bioscience, Inc.|DARE - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Daré Bioscience|Quick Liquidity darebioscience.com
- earnings and market ratios statistics:
DARE - Net Profit|Company Profit Forecast Dare Bioscience, Inc.|DARE - Price to Earnings Ratio|Projected Price to Earnings Ratio Daré Bioscience, Inc.|DARE - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Daré Bioscience, Inc.|DARE - Operating profit EBITDA|Net earnings per share for the last 12 months Daré Bioscience|DARE - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months darebioscience.com|DARE - Earnings growth in current year|Expected net earnings per share growth next year Dare Bioscience, Inc.
Fundamental valuation:DARE Dare Bioscience
Manufactured product of darebioscience.com

This indicator measures earnings per share (EPS) dynamics relative to the same period last year. A positive trend indicates increasing business efficiency, allowing investors to timely identify the asset's value acceleration phase. By analyzing the annual EPS growth trajectory, one can assess the impact of Dare Bioscience, Inc. (DARE) production line modernization on financial results. A stable workload across research sites provides the foundation for future capitalization.

Key competitors

Net earnings per share growth this year Organon & Co|TXMD (TherapeuticsMD Inc) - Earnings growth in current year|Earnings per share growth rate in current year Palatin Corp PTN